ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993

NCI Director Sets A Goal: Eliminate Suffering, Death From Cancer By 2015

February 14, 2003

DCE Technical Support Contracts Recompetition Approved in Concept

November 22, 1991

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014

Schmidt’s Term On Cancer Panel Expires, No Word On Reappointment

February 28, 1975

Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve

February 21, 1975